Home › Free Stock Grades › ALKS
Alkermes plc (ALKS) Stock Grade
ALKS · Healthcare
B+
Market Cap
$4.6B
P/E Ratio
19.1
Revenue Growth (YoY)
-5.3%
Net Margin
16.4%
Return on Equity
13.3%
Dividend Yield
None
About Alkermes plc's fundamentals
Alkermes is a $4.6 billion biotechnology company with a solid net margin of 16.4%, indicating efficient conversion of revenue to profit. However, the company faced a revenue decline of 5.3% year-over-year, suggesting headwinds in its product portfolio or market demand. With a P/E ratio of 19.1 and return on equity of 13.3%, the company trades at a moderate valuation relative to earnings while generating reasonable returns for shareholders. The company does not currently pay a dividend.